Single-molecule array assay reveals the prognostic impact of plasma LRIG1 in ovarian carcinoma.

Alexandra Lorenzzi Löfgren de Melo,Anna Linder,Karin Sundfeldt,David Lindquist,Håkan Hedman

Acta oncologica (Stockholm, Sweden)（2022）

引用 0|浏览4

暂无评分

摘要

LRIG1 plasma levels were elevated in patients with ovarian carcinoma, and high levels were associated with poor prognosis, suggesting that LRIG1 might be an etiologic factor and a potentially useful biomarker in ovarian carcinoma.

查看译文

关键词

LRIG1,Ovarian carcinoma,Simoa,biomarker,plasma,prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要